In vitro studies suggest that ghrelin may enhance the proliferation of prostate (Yeh et al, 2005) and pancreatic (Duxbury et al, 2003) cancer cells, but not of a lung cancer cell line, where it induced dose-dependent inhibition of cell proliferation and increased apoptosis (Cassoni et al, 2006). This evidence concerns the gene GHRL and lung carcinoma.